Meed Growth Corp. Awards 1.35 Million Stock Options to Directors and Officers with $0.10 Exercise Price

Details and Terms of Stock Option Grant

Meed Growth Corp. announced on July 17, 2026, that its board approved a significant equity compensation package totaling 1,350,000 stock options. The options were formally granted on July 14, 2026, to members of the board and executive management. Each option entitles the holder to purchase one common share at a fixed exercise price of $0.10.

These options vest immediately, allowing recipients full rights to exercise from the grant date. This immediate vesting contrasts with typical phased schedules where options become exercisable over months or years. The options remain valid for six years, expiring June 30, 2031, offering a broad timeframe for exercise.

Vesting and Exercise Details

All 1,350,000 options vested on July 14, 2026, enabling directors and officers to exercise their options at any time thereafter, subject to securities regulations and trading restrictions.

The $0.10 exercise price sets the strike price for purchasing common shares. While the announcement does not disclose Meed's current share price or valuation metrics, these factors will influence the options’ economic value.

Leadership Equity Incentive Strategy

Granting stock options to directors and officers aligns leadership incentives with shareholder value growth. By issuing options instead of direct shares or cash bonuses, Meed encourages focus on long-term share appreciation and company performance. The sizable grant of 1,350,000 options indicates a meaningful equity incentive to retain and motivate key management.

The immediate vesting and six-year exercise window provide flexibility for recipients and support Meed’s ability to attract and retain qualified leadership. The company did not disclose the number of recipients, allocation details, or whether this is a recurring or one-time grant.

Impact on Capital Structure and Shareholder Dilution

Exercising these 1,350,000 options would dilute existing shareholders by issuing new common shares at $0.10 each. The company did not disclose the total outstanding shares, so the dilution percentage cannot be determined.

No information was provided regarding existing stock option plans or whether this grant falls under an established equity compensation program. Investors should consult Meed’s management information circulars or proxy materials for full equity compensation context and dilution risk.

TSX Venture Exchange Disclosure and Regulatory Notes

Meed Growth Corp. trades on the TSX Venture Exchange under ticker MEED.P, catering to emerging growth companies. The July 17, 2026 announcement was disseminated via Newsfile Corp., a recognized Canadian newswire service.

The release includes standard disclaimers noting that neither the TSX Venture Exchange nor its Regulation Services Provider guarantees the accuracy or adequacy of the disclosure. It also states the information is not for distribution to U.S. newswire services, reflecting Canadian cross-border securities regulations.

Timing and Context of the Grant

The stock option grant was issued July 14, 2026, and publicly announced three days later. The announcement does not link the grant to any specific corporate event, financial milestone, or changes in board or management composition.

The six-year expiration date of June 30, 2031 offers recipients ample time to exercise options, though the rationale for this specific expiration date was not provided. Companies often align expiration dates with fiscal year ends or administrative schedules.

Additional Company Information and Disclosures

This disclosure focuses solely on the equity compensation event without detailing Meed’s broader business strategy, financial status, or recent financing activities. Investors seeking further insight should review Meed’s public filings with Canadian securities regulators, including quarterly and annual reports and material change filings.

The announcement does not indicate if the option grant coincided with other significant corporate developments such as financings, acquisitions, or leadership changes, which could provide important context.

Market Data and Share Price Context

The announcement lacks current trading price, volume, or historical share performance data for Meed. Investors must consult real-time TSX Venture Exchange data or Canadian financial sources to evaluate the option grant’s value relative to market conditions.

While the $0.10 exercise price is disclosed, without current market price information it is unclear whether the options are "in the money" or "out of the money." Only investors with access to current trading data can assess the intrinsic value.

Corporate Governance and Disclosure Compliance

This announcement exemplifies transparent executive compensation disclosure consistent with Canadian securities regulations for material changes. The detailed information on option quantity, exercise price, vesting, and expiration meets TSXV disclosure standards.

Matthew Gustavson, serving as both Chief Financial Officer and Director, is the designated contact for investor inquiries. His dual role is common in smaller public firms but may be relevant for investors evaluating governance structures and executive-board separation.